Biden Nominates Dr. Monica Bertagnolli, Renowned Oncologist, as Next NIH Director

Spread the love

Biden Nominates Dr. Monica Bertagnolli as Next NIH Director

President Joe Biden has selected Dr. Monica Bertagnolli to be the next director of the National Institutes of Health (NIH), as announced on Monday. Dr. Bertagnolli, a highly esteemed surgical oncologist, cancer researcher, educator, and physician-leader, has been nominated due to her exemplary vision and leadership qualities, which are essential to advancing the NIH’s mission of seeking fundamental knowledge and promoting human health.

A Pioneer in Scientific Discovery and Cancer Treatment

Throughout her career, Dr. Bertagnolli has been a trailblazer in scientific discovery and pushing the boundaries of possibility in cancer prevention and treatment. President Biden emphasized her remarkable contributions to improving cancer care for patients and ensuring equitable access to quality care across communities.

Impressive Achievements at the National Cancer Institute

Since October 2022, Dr. Bertagnolli has been serving as the director of the National Cancer Institute, where she has been instrumental in advancing President Biden’s Cancer Moonshot initiative to eradicate cancer. Under her leadership, the National Cancer Institute has fostered collaborations across sectors, leveraging partnerships and resources to launch groundbreaking programs in cancer prevention, early detection, and clinical trials. Notably, she spearheaded the development of a national navigation program for childhood cancers, augmenting the institute’s impact.

An Accomplished Surgeon and Researcher

Before her current role, Dr. Bertagnolli held a position as a surgical oncology professor at Harvard Medical School and worked as a surgeon at Brigham and Women’s Hospital. Widely recognized for her expertise in clinical and research oncology, she has significantly contributed to the understanding of gene mutations associated with gastrointestinal cancer and the role of inflammation in cancer growth.

Transitioning Leadership from Lawrence Tabak

Dr. Bertagnolli will succeed Lawrence Tabak, who has been serving as the acting director of the NIH since December 2021. Lawrence Tabak assumed the position after Francis Collins, who had led the federal agency since his nomination by President Barack Obama in 2009, stepped down. The appointment of Dr. Bertagnolli reflects President Biden’s confidence in her ability to lead the NIH and build upon the agency’s rich legacy of scientific advancement and public health promotion.

Source: ©Angela Rowlings/MediaNews Group/Boston Herald via Getty Images ; NBCnews
 Additionally, you can find more news on: www.sendasnews.com

Views:1021 3
Website | + posts

Yustika Kusuma Putri, she is social media marketer from Indonesia. I currently work as a Media Manager in Technologie Omicrom Sendas inc.
I'm passionate about staying up-to-date with the latest news and trends. I believe that being informed about what's happening in the world is essential to making informed decisions, both in business and in life.
That's why I'm excited to share my insights and provide you with updated information on these topics.


Spread the love